Polymyxin b sulfate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for polymyxin b sulfate and what is the scope of freedom to operate?
Polymyxin b sulfate
is the generic ingredient in five branded drugs marketed by Glaxosmithkline, Adrastea Pharma, Eugia Pharma, Fresenius Kabi Usa, Gland, Hikma, Rising, Xellia Pharms Aps, X Gen Pharms, Paddock Llc, Allergan, Bausch And Lomb, Epic Pharma Llc, Sandoz, and Somerset Theraps Llc, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.There are ten drug master file entries for polymyxin b sulfate. Seven suppliers are listed for this compound.
Summary for polymyxin b sulfate
US Patents: | 0 |
Tradenames: | 5 |
Applicants: | 15 |
NDAs: | 15 |
Drug Master File Entries: | 10 |
Finished Product Suppliers / Packagers: | 7 |
Raw Ingredient (Bulk) Api Vendors: | 11 |
Clinical Trials: | 6 |
What excipients (inactive ingredients) are in polymyxin b sulfate? | polymyxin b sulfate excipients list |
DailyMed Link: | polymyxin b sulfate at DailyMed |
Recent Clinical Trials for polymyxin b sulfate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Madonna Magdy Fahmy | Early Phase 1 |
University of Miami | N/A |
Bascom Palmer Eye Institute | N/A |
Pharmacology for polymyxin b sulfate
Drug Class | Polymyxin-class Antibacterial |
Medical Subject Heading (MeSH) Categories for polymyxin b sulfate
Anatomical Therapeutic Chemical (ATC) Classes for polymyxin b sulfate
US Patents and Regulatory Information for polymyxin b sulfate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Paddock Llc | POLYMYXIN B SULFATE | polymyxin b sulfate | POWDER;FOR RX COMPOUNDING | 062455-001 | Jul 27, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
X Gen Pharms | POLY-RX | polymyxin b sulfate | POWDER;FOR RX COMPOUNDING | 061578-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hikma | POLYMYXIN B SULFATE | polymyxin b sulfate | INJECTABLE;INJECTION | 060716-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Xellia Pharms Aps | POLYMYXIN B SULFATE | polymyxin b sulfate | INJECTABLE;INJECTION | 202766-001 | Jan 15, 2014 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Adrastea Pharma | POLYMYXIN B SULFATE | polymyxin b sulfate | INJECTABLE;INJECTION | 063000-001 | Sep 30, 1994 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.